{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:59:18Z","timestamp":1790873958148,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Keratinocytes are closely associated with innate immunity and inflammatory responses, and are dysregulated during the development of psoriasis, but the underlying mechanisms are not yet fully understood. This work aims to reveal the effects of long non-coding RNA (lncRNA) UCA1 in psoriatic keratinocytes. UCA1 was identified as a psoriasis-related lncRNA that highly expressed in psoriatic lesions. The transcriptome and proteome data of keratinocyte cell line HaCaT showed that UCA1 could positively regulate inflammatory functions, such as response to cytokine. Furthermore, UCA1 silencing decreased inflammatory cytokine secretion and innate immunity gene expression in HaCaT, its culture supernatant also decreased the migration and tube formation ability of vascular endothelial cells (HUVECs). Mechanistically, UCA1 activated the NF-\u03baB signaling pathway, which is regulated by HIF-1\u03b1 and STAT3. We also observed a direct interaction between UCA1 and N6-methyladenosine (m\n                    <jats:sup>6<\/jats:sup>\n                    A) methyltransferase METTL14. Knocking down METTL14 counteracted the effects of UCA1 silencing, indicating that it can suppress inflammation. In addition, the levels of m\n                    <jats:sup>6<\/jats:sup>\n                    A-modified HIF-1\u03b1 were decreased in psoriatic lesions, indicating that HIF-1\u03b1 is a potential target of METTL14. Taken together, this work indicates that UCA1 positively regulates keratinocyte-driven inflammation and psoriasis development by binding to METTL14, and activating HIF-1\u03b1 and NF-\u03baB signaling pathway. Our findings provide new insights into the molecular mechanisms of keratinocyte-driven inflammation in psoriasis.\n                  <\/jats:p>","DOI":"10.1038\/s41419-023-05790-4","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T23:51:49Z","timestamp":1681948309000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["LncRNA UCA1 promotes keratinocyte-driven inflammation via suppressing METTL14 and activating the HIF-1\u03b1\/NF-\u03baB axis in psoriasis"],"prefix":"10.1038","volume":"14","author":[{"given":"Yibo","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuhan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6747-1486","authenticated-orcid":false,"given":"Qinghai","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7612-4777","authenticated-orcid":false,"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,20]]},"reference":[{"key":"5790_CR1","first-page":"9","volume":"146","author":"E Farley","year":"2011","unstructured":"Farley E, Menter A. Psoriasis: comorbidities and associations. G Ital Dermatol Venereol. 2011;146:9\u201315.","journal-title":"G Ital Dermatol Venereol"},{"key":"5790_CR2","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker J. Psoriasis. Lancet. 2021;397:1301\u201315.","journal-title":"Lancet"},{"key":"5790_CR3","doi-asserted-by":"publisher","first-page":"1128154","DOI":"10.3389\/fmed.2023.1128154","volume":"10","author":"R Maglie","year":"2023","unstructured":"Maglie R, Solimani F, Didona D, Pipito C, Antiga E, Di Zenzo G. The cytokine milieu of bullous pemphigoid: Current and novel therapeutic targets. Front Med (Lausanne). 2023;10:1128154.","journal-title":"Front Med (Lausanne)"},{"key":"5790_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1684\/ecn.2022.0479","volume":"33","author":"CJ Papayannakos","year":"2022","unstructured":"Papayannakos CJ, Zhu D, Jung B, Rana AA, DeVoti JA, Abramson AL, et al. Toll-like receptor agonists, poly(I:C) and flagellin, lead to IL-36gamma induction with divergent release kinetics and differentially alter autophagy in primary human keratinocytes. Eur Cytokine Netw. 2022;33:19\u201329.","journal-title":"Eur Cytokine Netw"},{"key":"5790_CR5","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.jid.2020.10.012","volume":"141","author":"Y Sawada","year":"2021","unstructured":"Sawada Y, Gallo RL. Role of Epigenetics in the Regulation of Immune Functions of the Skin. J Invest Dermatol. 2021;141:1157\u201366.","journal-title":"J Invest Dermatol"},{"key":"5790_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-018-0541-9","volume":"10","author":"A Chandra","year":"2018","unstructured":"Chandra A, Senapati S, Roy S, Chatterjee G, Chatterjee R. Epigenome-wide DNA methylation regulates cardinal pathological features of psoriasis. Clin Epigenetics. 2018;10:108.","journal-title":"Clin Epigenetics"},{"key":"5790_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41586-019-1411-0","volume":"571","author":"G Cavalli","year":"2019","unstructured":"Cavalli G, Heard E. Advances in epigenetics link genetics to the environment and disease. Nature. 2019;571:489\u201399.","journal-title":"Nature"},{"key":"5790_CR8","doi-asserted-by":"publisher","first-page":"591629","DOI":"10.3389\/fcell.2020.591629","volume":"8","author":"YN Wang","year":"2020","unstructured":"Wang YN, Jin HZ. Transcriptome-Wide m(6)A Methylation in Skin Lesions From Patients With Psoriasis Vulgaris. Front Cell Dev Biol. 2020;8:591629.","journal-title":"Front Cell Dev Biol"},{"key":"5790_CR9","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3390\/cells11030506","volume":"11","author":"DE Adams","year":"2022","unstructured":"Adams DE, Shao WH. Epigenetic Alterations in Immune Cells of Systemic Lupus Erythematosus and Therapeutic Implications. Cells. 2022;11:506.","journal-title":"Cells"},{"key":"5790_CR10","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.2217\/epi-2021-0369","volume":"13","author":"L Shen","year":"2021","unstructured":"Shen L, Yu Y, Jiang M, Zhao J. Alteration of the m(6)A methylation landscape in a mouse model of scleroderma. Epigenomics. 2021;13:1867\u201383.","journal-title":"Epigenomics"},{"key":"5790_CR11","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","volume":"20","author":"S Zaccara","year":"2019","unstructured":"Zaccara S, Ries RJ, Jaffrey SR. Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol. 2019;20:608\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5790_CR12","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1126\/science.aau1646","volume":"361","author":"M Frye","year":"2018","unstructured":"Frye M, Harada BT, Behm M, He C. RNA modifications modulate gene expression during development. Science. 2018;361:1346\u20139.","journal-title":"Science"},{"key":"5790_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01652-3","volume":"21","author":"W Li","year":"2022","unstructured":"Li W, Hao Y, Zhang X, Xu S, Pang D. Targeting RNA N(6)-methyladenosine modification: a precise weapon in overcoming tumor immune escape. Mol Cancer. 2022;21:176.","journal-title":"Mol Cancer"},{"key":"5790_CR14","doi-asserted-by":"publisher","first-page":"e20210360","DOI":"10.1084\/jem.20210360","volume":"218","author":"AC Grenov","year":"2021","unstructured":"Grenov AC, Moss L, Edelheit S, Cordiner R, Schmiedel D, Biram A, et al. The germinal center reaction depends on RNA methylation and divergent functions of specific methyl readers. J Exp Med. 2021;218:e20210360.","journal-title":"J Exp Med"},{"key":"5790_CR15","doi-asserted-by":"publisher","first-page":"7304345","DOI":"10.1155\/2019\/7304345","volume":"2019","author":"M Tupikowska-Marzec","year":"2019","unstructured":"Tupikowska-Marzec M, Kolackov K, Zdrojowy-Welna A, Sloka NK, Szepietowski JC, Maj J. The Influence of FTO Polymorphism rs9939609 on Obesity, Some Clinical Features, and Disturbance of Carbohydrate Metabolism in Patients with Psoriasis. Biomed Res Int. 2019;2019:7304345.","journal-title":"Biomed Res Int"},{"key":"5790_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1032-0","volume":"18","author":"CJ Wang","year":"2019","unstructured":"Wang CJ, Zhu CC, Xu J, Wang M, Zhao WY, Liu Q, et al. The lncRNA UCA1 promotes proliferation, migration, immune escape and inhibits apoptosis in gastric cancer by sponging anti-tumor miRNAs. Mol Cancer. 2019;18:115.","journal-title":"Mol Cancer"},{"key":"5790_CR17","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1158\/1078-0432.CCR-06-0134","volume":"12","author":"XS Wang","year":"2006","unstructured":"Wang XS, Zhang Z, Wang HC, Cai JL, Xu QW, Li MQ, et al. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin Cancer Res. 2006;12:4851\u20138.","journal-title":"Clin Cancer Res"},{"key":"5790_CR18","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.omtn.2019.12.009","volume":"19","author":"Y Luan","year":"2020","unstructured":"Luan Y, Li X, Luan Y, Zhao R, Li Y, Liu L, et al. Circulating lncRNA UCA1 Promotes Malignancy of Colorectal Cancer via the miR-143\/MYO6 Axis. Mol Ther Nucleic Acids. 2020;19:790\u2013803.","journal-title":"Mol Ther Nucleic Acids"},{"key":"5790_CR19","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.hlc.2022.10.008","volume":"32","author":"Y Chen","year":"2022","unstructured":"Chen Y, Xue J, Fang D, Tian X. Clinical Value and Mechanism of Long Non-Coding RNA UCA1 in Acute Respiratory Distress Syndrome Induced by Cardiopulmonary Bypass. Heart Lung Circ. 2022;32:544\u201351.","journal-title":"Heart Lung Circ"},{"key":"5790_CR20","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/carcin\/bgac004","volume":"43","author":"X Zhang","year":"2022","unstructured":"Zhang X, Tang X, Pan L, Li Y, Li J, Li C. Elevated lncRNA-UCA1 upregulates EZH2 to promote inflammatory response in sepsis-induced pneumonia via inhibiting HOXA1. Carcinogenesis. 2022;43:371\u201381.","journal-title":"Carcinogenesis"},{"key":"5790_CR21","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jid.2019.04.029","volume":"140","author":"S Pei","year":"2020","unstructured":"Pei S, Chen J, Lu J, Hu S, Jiang L, Lei L, et al. The Long Noncoding RNA UCA1 Negatively Regulates Melanogenesis in Melanocytes. J Invest Dermatol. 2020;140:152\u201363 e155.","journal-title":"J Invest Dermatol"},{"key":"5790_CR22","doi-asserted-by":"publisher","first-page":"e52242","DOI":"10.1371\/journal.pone.0052242","volume":"8","author":"J Bigler","year":"2013","unstructured":"Bigler J, Rand HA, Kerkof K, Timour M, Russell CB. Cross-study homogeneity of psoriasis gene expression in skin across a large expression range. PLoS One. 2013;8:e52242.","journal-title":"PLoS One"},{"key":"5790_CR23","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.jaci.2019.10.041","volume":"145","author":"LE Tomalin","year":"2020","unstructured":"Tomalin LE, Russell CB, Garcet S, Ewald DA, Klekotka P, Nirula A, et al. Short-term transcriptional response to IL-17 receptor-A antagonism in the treatment of psoriasis. J Allergy Clin Immunol. 2020;145:922\u201332.","journal-title":"J Allergy Clin Immunol"},{"key":"5790_CR24","first-page":"97","volume":"93","author":"F Gran","year":"2020","unstructured":"Gran F, Kerstan A, Serfling E, Goebeler M, Muhammad K. Current Developments in the Immunology of Psoriasis. Yale J Biol Med. 2020;93:97\u2013110.","journal-title":"Yale J Biol Med"},{"key":"5790_CR25","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1016\/j.jid.2022.02.018","volume":"142","author":"YZ Huang","year":"2022","unstructured":"Huang YZ, Zheng YX, Zhou Y, Xu F, Cui YZ, Chen XY, et al. OAS1, OAS2, and OAS3 Contribute to Epidermal Keratinocyte Proliferation by Regulating Cell Cycle and Augmenting IFN-1\u2012Induced Jak1\u2012Signal Transducer and Activator of Transcription 1 Phosphorylation in Psoriasis. J Invest Dermatol. 2022;142:2635\u201345 e2639.","journal-title":"J Invest Dermatol"},{"key":"5790_CR26","doi-asserted-by":"publisher","first-page":"589","DOI":"10.15252\/emmm.201607027","volume":"9","author":"H Zhu","year":"2017","unstructured":"Zhu H, Lou F, Yin Q, Gao Y, Sun Y, Bai J, et al. RIG-I antiviral signaling drives interleukin-23 production and psoriasis-like skin disease. EMBO Mol Med. 2017;9:589\u2013604.","journal-title":"EMBO Mol Med"},{"key":"5790_CR27","first-page":"225","volume":"20","author":"YJ Zhang","year":"2019","unstructured":"Zhang YJ, Sun YZ, Gao XH, Qi RQ. Integrated bioinformatic analysis of differentially expressed genes and signaling pathways in plaque psoriasis. Mol Med Rep. 2019;20:225\u201335.","journal-title":"Mol Med Rep"},{"key":"5790_CR28","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/kjm2.12363","volume":"37","author":"XL Ma","year":"2021","unstructured":"Ma XL, Wen GD, Yu C, Zhao Z, Gao N, Liu ZY. LncRNA UCA1 negatively regulates NF-kB activity in psoriatic keratinocytes through the miR125a-A20 axis. Kaohsiung J Med Sci. 2021;37:172\u201380.","journal-title":"Kaohsiung J Med Sci"},{"key":"5790_CR29","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1126\/science.aan4665","volume":"360","author":"MD Kornberg","year":"2018","unstructured":"Kornberg MD, Bhargava P, Kim PM, Putluri V, Snowman AM, Putluri N, et al. Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity. Science. 2018;360:449\u201353.","journal-title":"Science"},{"key":"5790_CR30","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1365-2133.2008.08889.x","volume":"160","author":"A Henno","year":"2009","unstructured":"Henno A, Blacher S, Lambert C, Colige A, Seidel L, Noel A, et al. Altered expression of angiogenesis and lymphangiogenesis markers in the uninvolved skin of plaque-type psoriasis. Br J Dermatol. 2009;160:581\u201390.","journal-title":"Br J Dermatol"},{"key":"5790_CR31","doi-asserted-by":"crossref","unstructured":"Zheng H, Gu L, Wang Z, Zhou H, Zhang C, Teng X, et al. Establishing Transcription Profile of Psoriasiform Cutaneous In Vitro using HaCaT Cells Stimulated with Combination of Cytokines. J Vis Exp. 2021;169.","DOI":"10.3791\/61537"},{"key":"5790_CR32","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1016\/j.jid.2022.02.016","volume":"142","author":"Z Yu","year":"2022","unstructured":"Yu Z, Yu Q, Xu H, Dai X, Yu Y, Cui L, et al. IL-17A Promotes Psoriasis-Associated Keratinocyte Proliferation through ACT1-Dependent Activation of YAP-AREG Axis. J Invest Dermatol. 2022;142:2343\u201352.","journal-title":"J Invest Dermatol"},{"key":"5790_CR33","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.jid.2021.06.019","volume":"142","author":"RS Gangwar","year":"2022","unstructured":"Gangwar RS, Gudjonsson JE, Ward NL. Mouse Models of Psoriasis: A Comprehensive Review. J Invest Dermatol. 2022;142:884\u201397.","journal-title":"J Invest Dermatol"},{"key":"5790_CR34","doi-asserted-by":"crossref","first-page":"e24392","DOI":"10.1002\/jcla.24392","volume":"36","author":"J Wang","year":"2022","unstructured":"Wang J, Feng Q, Wu Y, Wang H. Involvement of blood lncRNA UCA1 in sepsis development and prognosis, and its correlation with multiple inflammatory cytokines. J Clin Lab Anal. 2022;36:e24392.","journal-title":"J Clin Lab Anal"},{"key":"5790_CR35","doi-asserted-by":"publisher","first-page":"e23697","DOI":"10.1002\/jcla.23697","volume":"35","author":"B Ren","year":"2021","unstructured":"Ren B, Song Z, Chen L, Niu X, Feng Q. Long non-coding RNA UCA1 correlates with elevated disease severity, Th17 cell proportion, inflammatory cytokines, and worse prognosis in acute ischemic stroke patients. J Clin Lab Anal. 2021;35:e23697.","journal-title":"J Clin Lab Anal"},{"key":"5790_CR36","doi-asserted-by":"publisher","first-page":"8939","DOI":"10.7150\/thno.45178","volume":"10","author":"D Jian","year":"2020","unstructured":"Jian D, Wang Y, Jian L, Tang H, Rao L, Chen K, et al. METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications. Theranostics. 2020;10:8939\u201356.","journal-title":"Theranostics"},{"key":"5790_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04156-y","volume":"12","author":"Z Lu","year":"2021","unstructured":"Lu Z, Liu H, Song N, Liang Y, Zhu J, Chen J, et al. METTL14 aggravates podocyte injury and glomerulopathy progression through N(6)-methyladenosine-dependent downregulating of Sirt1. Cell Death Dis. 2021;12:881.","journal-title":"Cell Death Dis"},{"key":"5790_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25710-4","volume":"12","author":"Z Xie","year":"2021","unstructured":"Xie Z, Yu W, Zheng G, Li J, Cen S, Ye G, et al. TNF-alpha-mediated m(6)A modification of ELMO1 triggers directional migration of mesenchymal stem cell in ankylosing spondylitis. Nat Commun. 2021;12:5373.","journal-title":"Nat Commun"},{"key":"5790_CR39","doi-asserted-by":"publisher","first-page":"e1009530","DOI":"10.1371\/journal.ppat.1009530","volume":"17","author":"J Xu","year":"2021","unstructured":"Xu J, Cai Y, Ma Z, Jiang B, Liu W, Cheng J, et al. The RNA helicase DDX5 promotes viral infection via regulating N6-methyladenosine levels on the DHX58 and NFkappaB transcripts to dampen antiviral innate immunity. PLoS Pathog. 2021;17:e1009530.","journal-title":"PLoS Pathog"},{"key":"5790_CR40","doi-asserted-by":"publisher","first-page":"e2100606","DOI":"10.1002\/advs.202100606","volume":"8","author":"F Qin","year":"2021","unstructured":"Qin F, Cai B, Zhao J, Zhang L, Zheng Y, Liu B, et al. Methyltransferase-Like Protein 14 Attenuates Mitochondrial Antiviral Signaling Protein Expression to Negatively Regulate Antiviral Immunity via N(6) -methyladenosine Modification. Adv Sci (Weinh). 2021;8:e2100606.","journal-title":"Adv Sci (Weinh)"},{"key":"5790_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-02833-y","volume":"11","author":"H Liu","year":"2020","unstructured":"Liu H, Xu Y, Yao B, Sui T, Lai L, Li Z. A novel N6-methyladenosine (m6A)-dependent fate decision for the lncRNA THOR. Cell Death Dis. 2020;11:613.","journal-title":"Cell Death Dis"},{"key":"5790_CR42","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.bbagrm.2018.12.002","volume":"1862","author":"H Coker","year":"2019","unstructured":"Coker H, Wei G, Brockdorff N. m6A modification of non-coding RNA and the control of mammalian gene expression. Biochim Biophys Acta Gene Regul Mech. 2019;1862:310\u20138.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"5790_CR43","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/cas.12461","volume":"105","author":"Z Li","year":"2014","unstructured":"Li Z, Li X, Wu S, Xue M, Chen W. Long non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase 2 through the mTOR-STAT3\/microRNA143 pathway. Cancer Sci. 2014;105:951\u20135.","journal-title":"Cancer Sci"},{"key":"5790_CR44","doi-asserted-by":"publisher","first-page":"6901","DOI":"10.1007\/s13277-014-1925-x","volume":"35","author":"M Xue","year":"2014","unstructured":"Xue M, Li X, Li Z, Chen W. Urothelial carcinoma associated 1 is a hypoxia-inducible factor-1alpha-targeted long noncoding RNA that enhances hypoxic bladder cancer cell proliferation, migration, and invasion. Tumour Biol. 2014;35:6901\u201312.","journal-title":"Tumour Biol"},{"key":"5790_CR45","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/j.jaci.2022.01.029","volume":"149","author":"D Redhu","year":"2022","unstructured":"Redhu D, Franke K, Aparicio-Soto M, Kumari V, Pazur K, Illerhaus A, et al. Mast cells instruct keratinocytes to produce thymic stromal lymphopoietin: Relevance of the tryptase\/protease-activated receptor 2 axis. J Allergy Clin Immunol. 2022;149:2053\u201361.e6.","journal-title":"J Allergy Clin Immunol"},{"key":"5790_CR46","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.18632\/aging.202320","volume":"13","author":"L Jiang","year":"2020","unstructured":"Jiang L, Huang J, Hu Y, Lei L, Ouyang Y, Long Y, et al. Identification of the ceRNA networks in alpha-MSH-induced melanogenesis of melanocytes. Aging (Albany NY). 2020;13:2700\u201326.","journal-title":"Aging (Albany NY)"},{"key":"5790_CR47","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/ng.311","volume":"41","author":"RP Nair","year":"2009","unstructured":"Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D, et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet. 2009;41:199\u2013204.","journal-title":"Nat Genet"},{"key":"5790_CR48","doi-asserted-by":"publisher","first-page":"e2737","DOI":"10.1371\/journal.pone.0002737","volume":"3","author":"Y Yao","year":"2008","unstructured":"Yao Y, Richman L, Morehouse C, de los Reyes M, Higgs BW, Boutrin A, et al. Type I interferon: potential therapeutic target for psoriasis? PLoS One. 2008;3:e2737.","journal-title":"PLoS One"},{"key":"5790_CR49","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1038\/jid.2012.184","volume":"132","author":"M Suarez-Farinas","year":"2012","unstructured":"Suarez-Farinas M, Li K, Fuentes-Duculan J, Hayden K, Brodmerkel C, Krueger JG. Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis. J Invest Dermatol. 2012;132:2552\u201364.","journal-title":"J Invest Dermatol"},{"key":"5790_CR50","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/jid.2013.269","volume":"134","author":"A Jabbari","year":"2014","unstructured":"Jabbari A, Suarez-Farinas M, Fuentes-Duculan J, Gonzalez J, Cueto I, Franks AG Jr, et al. Dominant Th1 and minimal Th17 skewing in discoid lupus revealed by transcriptomic comparison with psoriasis. J Invest Dermatol. 2014;134:87\u201395.","journal-title":"J Invest Dermatol"},{"key":"5790_CR51","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.4049\/jimmunol.1301737","volume":"192","author":"CB Russell","year":"2014","unstructured":"Russell CB, Rand H, Bigler J, Kerkof K, Timour M, Bautista E, et al. Gene expression profiles normalized in psoriatic skin by treatment with brodalumab, a human anti-IL-17 receptor monoclonal antibody. J Immunol. 2014;192:3828\u201336.","journal-title":"J Immunol"},{"key":"5790_CR52","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1038\/jid.2014.28","volume":"134","author":"B Li","year":"2014","unstructured":"Li B, Tsoi LC, Swindell WR, Gudjonsson JE, Tejasvi T, Johnston A, et al. Transcriptome analysis of psoriasis in a large case-control sample: RNA-seq provides insights into disease mechanisms. J Invest Dermatol. 2014;134:1828\u201338.","journal-title":"J Invest Dermatol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-05790-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-05790-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-05790-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,10]],"date-time":"2023-12-10T19:39:55Z","timestamp":1702237195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-05790-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,20]]},"references-count":52,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["5790"],"URL":"https:\/\/doi.org\/10.1038\/s41419-023-05790-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2388979\/v1","asserted-by":"object"}]},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,20]]},"assertion":[{"value":"3 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Specimens were collected from the Third Xiangya Hospital, China. The experiments involving human tissues and cells were approved by the ethics committee of Third Xiangya Hospital, Central South University (approval documents: No. 2020-S066, No. 2021-S328). All procedures involving human tissues were in accordance with the ethical standards of the institutional and national research committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"279"}}